Biomedical research institute
    You are here: Home / Institute

    Institut Cochin: A research institute in basic biology dedicated to human pathology

    The Institut Cochin is one of the biggest French multidisciplinary biomedical research centers, it is affiliated to Inserm (U1016), CNRS (UMR 8104) and the Université de Paris (UMR-S1016). The Institute is located on the Cochin-Port-Royal hospitals campus (AP-HP Paris Centre), within 5 buildings (Méchain, Gustave Roussy, Faculté Cochin, Hardy and Cassini).



    Directors board


    A scientific advisory board (SAB) has been advising the Institut Cochin since 2013, it is composed of 15 international researchers who are leaders in their field, and it is chaired by Eric Gilson



    • Elucidate the biological mechanisms of the main physiological and pathological pathways, ranging from the most fundamental molecular and cellular studies to translational research
    • Increase exchanges and collaborations between the teams of the Institut Cochin and the clinical services of the AP-HP Paris Centre hospitals, strengthen the networks "from the bench to the patient's bed"
    • Accelerate technology transfer to pharmaceutical / biotechnology companies and to clinics
    • Develop cutting-edge technologies for the benefit of researchers
    • Transmit knowledge and skills through strong involvement in teaching and tutoring,
    • Make our work and the scientific approaches known to the general public through open-lab actions.


    Key figures




    The Institut Cochin is organized in 3 scientific departments, each made up of 10 to 17 teams, and a technology department:

    • Endocrinology, metabolism and Diabetes (EMD)Homeostasis and metabolic diseases: diabetes, obesity, steatosis, iron overload; endocrine diseases, microbiota
    • Development, Reproduction and Cancer (DRC)Infertility and placental diseases, embryonic development, solid and hematological cancers, cell differentiation, stem cells
    • Infection, Immunity and Inflammation (3I): Host-pathogen interactions (viruses, bacteria, parasites), local and systemic immune responses, vaccinology, immunotherapies, inflammatory or autoimmune diseases
    • Technological platforms: since its creation, the Institut Cochin has invested heavily in the development of efficient and innovative technological platforms, at the service of its teams, as well as all of the University's teams and external public or private teams:



     The Institut Cochin: History

    The Institut Cochin was created on 01/01/2002 as a multidisciplinary, biomedical Research Center affiliated to the University Paris 5, INSERM and CNRS, with Prof Axel Kahn as the director. This creation was indeed a response and a support of these institutions to the strong will and determination of a dozen of previously independent INSERM or CNRS laboratories (grouped within a federative structure since 1990: the Institut Cochin of Molecular Genetics, ICGM, head by Prof. Jean-Paul Levy) to join their efforts to create a scientific and technological environment prone to provide their approximately 500 staff members with the most stimulating working conditions. 

    The Institut Cochin was renewed for 5 years on jan. 1st, 2019.